Velsipity 2 mg, Filmtabletten

7680693770010 CH-69377 Filmtabletten
Velsipity 2 mg, Filmtabletten
Velsipity 2 mg, Filmtabletten
Velsipity 2 mg, Filmtabletten
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
15/08/2025
Summary of Product Characteristics
Français
15/08/2025
Summary of Product Characteristics
Italien
15/08/2025
Patient information leaflet
Allemand
23/07/2025
Patient information leaflet
Français
23/07/2025
Patient information leaflet
Italien
23/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
0.0156 MG Substance HBESI
(N/A)
- Substance FIMDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 893.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2024

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69377
Drug name
Velsipity, Filmtabletten
Galenic form
FILM
ATC Code
L04AE05
Authorization status
Z
Dispensing category
B
First authorization
10/09/2024
Authorization expiration date
09/09/2029
IT Number
07.15.0.
Domain
Human medicine
Field of application
Behandlung von erwachsenen Patienten mit mässig bis schwerer aktiver Colitis ulcerosa (CU), die entweder auf eine herkömmliche Therapie oder ein Biologikum unzureichend angesprochen haben, nicht mehr ansprechen oder diese nicht vertragen

Package details

Description (FR)
VELSIPITY cpr pell 2 mg 28 pce
Description (DE)
VELSIPITY Filmtabl 2 mg 28 Stk
Market launch
10/09/2024
Narcotic (BTM)
No